Pacific Biosciences of California, Inc.

Healthcare

NASDAQ:PACB · NASDAQ Global Select

Market Cap $431.74M Beta 2.32 P/E (TTM) -3.3

$1.40 +3.17%

+$0.04 today

52W Low $1.09High $2.73

Vol 4.18M · Avg 6.06M

EPS (TTM) -$0.42Medical - Devices

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+17.65%

Period High

$2.67

Period Low

$1.12

Latest

$1.40

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Butterfly Network, Inc.

NYSE:BFLY

$1.98B

Iovance Biotherapeutics, Inc.

NASDAQ:IOVA

$1.40B

Integra LifeSciences Holdings Corporation

NASDAQ:IART

$1.38B

Avanos Medical, Inc.

NYSE:AVNS

$1.17B

SI-BONE, Inc.

NASDAQ:SIBN

$701.72M

Ginkgo Bioworks Holdings, Inc.

NYSE:DNA

$577.80M

Fulgent Genetics, Inc.

NASDAQ:FLGT

$513.20M

Orthofix Medical Inc.

NASDAQ:OFIX

$371.56M

DarioHealth Corp.

NASDAQ:DRIO

$50.74M

POMDOCTOR Ltd

POM

$9.23M

What is the latest PACB filing?

The latest filing shown is 4 dated Jun 4, 2026.

How many recent filings does PACB have?

Intrinsic Alpha currently shows 20 recent filings for PACB.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.